Combat Medical, a medical device company optimising the delivery and efficacy of cancer therapeutics, has raised £2.6 million in the first close of a Series A financing to advance its hyperthermic intravesical chemotherapy treatment, HIVEC, through phase 3 clinical trials and toward FDA registration.

The round was led by T&J Meyer Family Foundation, and included investment from Varia Ventures, NW Angel Fund and non-institutional family offices and individuals.